Rigel Pharmaceuticals (RIGL) Inventory (2018 - 2026)

Rigel Pharmaceuticals has reported Inventory for 9 years, with the latest figure at $11.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 150.1% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.7 million (up 150.1% YoY), and the FY2025 full-year result was $11.5 million, up 91.7% from the prior year.
• Inventory for Q1 2026 stood at $11.7 million, up from $11.5 million in the prior quarter.
• The five-year high for Inventory was $13.3 million in Q3 2025, with the low at $4.7 million in Q1 2025.
• Average Inventory over 5 years is $8.2 million, with a median of $7.1 million recorded in 2022.
• Year-over-year, Inventory plunged 40.61% in 2024 and surged 178.07% in 2025.
• Tracing RIGL's Inventory over 5 years: stood at $9.1 million in 2022, then tumbled by 39.44% to $5.5 million in 2023, then climbed by 8.69% to $6.0 million in 2024, then surged by 91.7% to $11.5 million in 2025, then increased by 1.27% to $11.7 million in 2026.
• The last three Inventory figures came in at $11.7 million (Q1 2026), $11.5 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.

Peer Comparison